# Quinta Analytica s.r.o. – FDA Inspection, Feb 5, 2016

Source: https://www.keypedia.com/records/fda_inspections/quinta-analytica-sro/174e66e8-b076-49b5-a3d3-1604cf7221b6
Source feed: FDA_Inspections

> FDA inspection 961301 of Quinta Analytica s.r.o., February 05, 2016. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 961301
- Company Name: Quinta Analytica s.r.o.
- Inspection Date: 2016-02-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1260984 - 2025-01-10](https://www.keypedia.com/records/fda_inspections/quinta-analytica-sro/41d6e605-2cc1-4287-b23d-b350cbd2761d)
- FDA Inspection 1191579 - 2022-11-03
- FDA Inspection 1155913 - 2021-04-20
- [FDA Inspection 1093399 - 2019-01-16](https://www.keypedia.com/records/fda_inspections/quinta-analytica-sro/3d427b43-5a6c-4c93-82e3-0ee43e59ad18)
- FDA Inspection 826686 - 2013-03-27

Company: https://www.keypedia.com/companies/quinta-analytica-sro/f26231ff-818d-4ba0-b952-72115b356982

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c